BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 17653753)

  • 1. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
    Ahmadieh H; Vafi N
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
    Narayanan R; Shah VA
    Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.
    Song WK; Koh HJ; Kwon OW; Byeon SH; Lee SC
    Acta Ophthalmol; 2009 Feb; 87(1):100-1. PubMed ID: 19178391
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
    Song JH; Bae JH; Rho MI; Lee SC
    Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT].
    Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
    J Fr Ophtalmol; 2012 Sep; 35(7):508-13. PubMed ID: 22695057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
    Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
    Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
    Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
    Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
    Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.
    Papastefanou VP; Pefkianaki M; Al Harby L; Arora AK; Cohen VM; Andrews RM; Sagoo MS
    Eye (Lond); 2016 Jun; 30(6):843-9. PubMed ID: 27034203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM; Lai TY; Liu DT; Lam DS
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.
    Jang JH; Kim KH; Lee SJ; Park JM
    Korean J Ophthalmol; 2012 Dec; 26(6):478-80. PubMed ID: 23204807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
    Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma.
    Szelog JT; Bonini Filho MA; Lally DR; de Carlo TE; Duker JS
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):69-72. PubMed ID: 26731212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab.
    Leu J; Schrage NF; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1723-5. PubMed ID: 17605026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
    Artunay O; Rasier R; Yuzbasioglu E; Sengül A; Bahcecioglu H
    Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.